Categories: Market News

What to look for when Philip Morris (PM) reports its Q2 2025 earnings results

Shares of Philip Morris International Inc. (NYSE: PM) stayed green on Monday. The stock has gained 14% over the past three months. The tobacco company is scheduled to report its earnings results for the second quarter of 2025 on Tuesday, July 22, before market opens. Here’s a look at what to expect from the earnings report:

Revenue

Analysts are projecting revenue of $10.3 billion for Philip Morris in the second quarter of 2025, which indicates a growth of 9% from the same period last year. In the first quarter of 2025, revenue increased nearly 6% year-over-year to $9.3 billion.

Earnings

Philip Morris has guided for adjusted earnings per share of $1.80-1.85 for Q2 2025. Analysts are predicting EPS of $1.86. This compares to adjusted EPS of $1.59 reported in Q2 2024. In Q1 2025, adjusted EPS rose nearly 13% YoY to $1.69.

Points to note

Philip Morris’ smoke-free business, led by IQOS and Zyn, is expected to keep up its momentum in the second quarter. The company’s smoke-free products are available in 95 markets, with 46 markets having a multi-category portfolio. In Q1, the smoke-free business saw double-digit growth in volumes, revenues and gross profit.

IQOS is expected to hold its leading position as it continues to perform well in markets such as Japan and Europe, with double-digit growth in regions like Spain, Germany and Greece. The product is also gaining share in places like Jakarta, Seoul and Mexico City.

Zyn is expected to strengthen its position in the oral nicotine pouch category. Last quarter, Zyn volumes grew 53% and it is gaining traction in emerging markets like South Africa. Recent launches in regions like UK, Poland and Italy are showing promising results.

PM’s combustibles business is expected to stay resilient in a declining market helped by volume growth and strong pricing. The Marlboro brand continues to gain market share. Last quarter, the company’s share of the overall cigarette category increased to 24.8%.

Share
Published by

Recent Posts

Aramark Holdings Q1 Revenue Tops Estimates; Shares Mixed After Close

Aramark Holdings Corp (NYSE: ARMK) shares closed at about $38.77 on Monday, marking a modest…

11 minutes ago

S&P Global (SPGI) reports double-digit growth in Q4 adj. earnings; revenue up 9%

S&P Global (NYSE: SPGI), a leading provider of financial intelligence solutions, reported strong earnings growth…

36 minutes ago

Fiserv (FISV) Earnings: 4Q25 Key Numbers

Fiserv Inc. (NASDAQ: FISV) reported its fourth quarter 2025 earnings results today. Revenue increased 1%…

49 minutes ago

Incyte Corporation Reports Strong 2025 Fiscal Results and Provides 2026 Guidance

Incyte achieved total revenue of $5.14 billion for the full year 2025, a 21% year-over-year…

51 minutes ago

CVS Health Reports Record 2025 Revenue of $402.1 Billion and Reaffirms 2026 Earnings Guidance

CVS Health Corporation (NYSE: CVS) reported record full-year 2025 consolidated revenues of $402.1 billion, a…

1 hour ago

CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline

Healthcare solutions company CVS Health Corporation (NYSE: CVS) on Monday reported an increase in revenues…

2 hours ago